Recent Insights Into Native Valve Infective Endocarditis: JACC Focus Seminar 4/4

J Am Coll Cardiol. 2024 Apr 16;83(15):1431-1443. doi: 10.1016/j.jacc.2023.12.043.

Abstract

This focused review highlights the latest issues in native valve infective endocarditis. Native valve disease moderately increases the risk of developing infective endocarditis. In 2023, new diagnostic criteria were published by the Duke-International Society of Cardiovascular Infectious Diseases group. New pathogens were designated as typical, and findings on computed tomography imaging were included as diagnostic criteria. It is now recognized that a multidisciplinary approach to care is vital, and the role of an "endocarditis team" is highlighted. Recent studies have suggested that a transition from intravenous to oral antibiotics in selected patients may be reasonable, and the role of long-acting antibiotics is discussed. It is also now clear that an aggressive surgical approach can be life-saving in some patients. Finally, results of several recent studies have suggested there is an association between dental and other invasive procedures and an increased risk of developing infective endocarditis. Moreover, data indicate that antibiotic prophylaxis may be effective in some scenarios.

Keywords: 18F-fluorodeoxyglucose positron emission tomography-computed tomography; cardiac computed tomography; diagnostic criteria; endocarditis team; infective endocarditis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Endocarditis* / diagnosis
  • Endocarditis* / etiology
  • Endocarditis, Bacterial* / diagnosis
  • Fluorodeoxyglucose F18
  • Heart Valve Prosthesis* / adverse effects
  • Humans
  • Positron Emission Tomography Computed Tomography / methods
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents
  • Fluorodeoxyglucose F18